| Author |
Goveia, Jermaine Farrar, Christian T. Seano, Giorgio Huang, Yuhui Amoozgar, Zohreh Kamoun, Walid S. Marijt, Koen A. Fukumura, Dai Peterson, Teresa E. Kloepper, Jonas Chatterjee, Sampurna Kirkpatrick, Nathaniel D. Jung, Keehoon Jain, Rakesh K. Vardam, Trupti Leow, Ching Ching Datta, Meenal Snuderl, Matija Xu, Lei Duda, Dan G. Batista, Ana Batchelor, Tracy T. Muzikansky, Alona |
| Description |
Author Affiliation: Peterson TE ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Kirkpatrick ND ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Huang Y ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Farrar CT ( Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129); Marijt KA ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Kloepper J ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Datta M ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Amoozgar Z ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Seano G ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Jung K ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Kamoun WS ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Vardam T ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Snuderl M ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Goveia J ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Chatterjee S ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Batista A ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Muzikansky A ( Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston); Leow CC ( Department of Translational Medicine Oncology, MedImmune, Gaithersburg, MD 20878); Xu L ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Batchelor TT ( Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.); Duda DG ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Fukumura D ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); Jain RK ( Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114); |
